NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Anthos Therapeutics, Inc.
Quercis Pharma AG
Daiichi Sankyo
GlaxoSmithKline
Rovi Pharmaceuticals Laboratories